Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 3, 2008, Pages 319-325

  Mokaddas, E ^a   Ahmad, Suhail ^a   Samir, I ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Chest Diseases Hospital Kuwait   (Kuwait)

Author keywords

Drug resistance; Incidence; Kuwait; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM ISOLATE; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; INCIDENCE; INFECTION SENSITIVITY; KUWAIT; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; KUWAIT; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 40549085678     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Frieden T R, Sterling T R, Munsiff S S, Watt C J, Dye C. Tuberculosis. Lancet 2003; 362: 887-899.
2. Harries A D, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006; 100: 415-431.
3. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva, Switzerland: WHO, 2007.
4. Wells C D, Cegielski P J, Nelson L J, et al. HIV infection and multidrug-resistant tuberculosis - the perfect storm. J Infect Dis 2007; 196 (Suppl): S86-S107.
5. Aziz M A, Wright A, Laszlo A, et al., for the WHO/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance surveillance. Epidemiology of anti-tuberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368: 2142-2154.
6. Zignol M, Hosseini M S, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
7. Sharma S K, Mohan A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 2006; 130: 261-272.
8. Meacci F, Orru G, Iona E, et al. Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient. J Clin Microbiol 2005; 43: 3114-3120.
9. Behbehani N, Abal A, Al-Shami A, Enarson D A. Epidemiology of tuberculosis in Kuwait from 1965 to 1999. Int J Tuberc Lung Dis 2002; 6: 465-469.
10. Abal A T, Abul H T, Syabbalo N C. Primary drug resistance of Mycobacterium tuberculosis to first line antitubercular agents at Kuwait Chest Diseases Hospital during 1992-1995. Med Principles Pract 1998; 7: 237-245.
11. Metchock B G, Nolte F S, Wallace R J Jr. Mycobacterium. In: Murray P R, Baron E J, Pfaller M A, Tenover F C, Yolken R H, eds. Manual of clinical microbiology. 7th ed. Washington, DC, USA: American Society for Microbiology, 1999: pp 399-437.
12. Siddiqi S H. BACTEC TB System product and procedure manual. Sparks, MD, USA: Becton-Dickinson, 1995.
13. Ahmad S, Jaber A-A, Mokaddas E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis 2007; 87: 123-129.
14. Scarparo C, Ricordi P, Ruggiero G, Piccoli P. Evaluation of the fully automated MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with radiometric BACTEC 460TB method. J Clin Microbiol 2004; 42: 1109-1114.
15. Laszlo A, Siddiqi S H. Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-α-acetylamino-β-hydroxypropiophenone. J Clin Microbiol 1984; 19: 694-698.
16. Mokaddas E, Ahmad S. Development and evaluation of a multiplex PCR for rapid detection and differentiation of Mycobacterium tuberculosis complex members from non-tuberculous mycobacteria. Jap J Infect Dis 2007; 60: 140-144.
17. Siddiqi S H, Hawkins J, Laszlo A. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by radiometric procedure and two conventional methods. J Clin Microbiol 1985; 22: 919-923.
18. Abal A T, Ahmad S, Mokaddas E. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Microb Drug Resist 2002; 8: 99-105.
19. Ahmad S, Mokaddas E. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. Int J Antimicrob Agents 2004; 23: 473-479.
20. Ahmad S, Mokaddas E, Fares E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai. Diagn Microbiol Infect Dis 2002; 44: 245-252.
21. Ahmad S, Mokaddas E. The occurrence of rare rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 2005; 26: 205-212.
22. Mokaddas E, Ahmad S, Abal A T. Molecular fingerprinting of isoniazid-resistant Mycobacterium tuberculosis isolates from Chest Disease Hospital in Kuwait. Microbiol Immunol 2002; 46: 767-771.
23. Mokaddas E, Ahmad S, Abal A T, Al-Shami A S. Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait. Ann Saudi Med 2005; 25: 150-153.
24. Alrajhi A A, Al-Barrak A M. Mycobacterium tuberculosis susceptibility in Saudi Arabia. Saudi Med J 2002; 23: 1227-1231.
25. Kordy F N S, Al-Thawadi S, Alrajhi A A. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis 2004; 8: 1007-1011.
26. Araj G F, Itani L, Kanj N A. Comparative study of antituberculous drug resistance among Mycobacterium tuberculosis isolates recovered at the American University of Beirut Medical Center: 1996-1998 vs. 1994-1998. Leb Med J 2000; 48: 18-22.
27. Abbadi S, Rashed H G, Morlock G P, Woodley C L, El Shanawy O, Cooksey R C. Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. J Clin Microbiol 2001; 39: 2330-2334.
28. American Thoracic Society/Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
29. Whalen C C. Diagnosis of latent tuberculosis infection: measure for measure. JAMA 2005; 293: 2785-2787.
30. Nahid P, Pai M, Hopewell P C. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 2006; 3: 103-110.
31. Rieder H L, Snider D E Jr, Cauthen G M. Extra-pulmonary tuberculosis in the United States. Am Rev Respir Dis 1990; 141: 347-351.
32. Golden M P, Vikram H R. Extra-pulmonary tuberculosis: an overview. Am Fam Phys 2005; 72: 1761-1768.
33. Cailhol J, Decludt B, Che D. Socio-demographic factors that contribute to the development of extra-pulmonary tuberculosis were identified. J Clin Epidemiol 2005; 58: 1066-1071.